EP Patent
EP2493858B1 — Androgen receptor modulating compounds
Assigned to Orion Oyj · Expires 2014-07-02 · 12y expired
What this patent protects
Patent listed against Nubeqa.
Drugs covered by this patent
- Nubeqa (darolutamide) · Bayer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.